Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $13.1 million.

  • Ironwood Pharmaceuticals' Prepaid Assets fell 792.76% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 792.76%. This contributed to the annual value of $11.9 million for FY2024, which is 74.09% down from last year.
  • Ironwood Pharmaceuticals' Prepaid Assets amounted to $13.1 million in Q3 2025, which was down 792.76% from $12.7 million recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Prepaid Assets peaked at $22.5 million during Q2 2023, and registered a low of $7.0 million during Q3 2022.
  • Over the past 5 years, Ironwood Pharmaceuticals' median Prepaid Assets value was $12.0 million (recorded in 2023), while the average stood at $12.1 million.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Prepaid Assets surged by 15833.69% in 2023 and then tumbled by 3534.22% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Prepaid Assets (Quarter) stood at $8.7 million in 2021, then dropped by 11.21% to $7.7 million in 2022, then skyrocketed by 55.7% to $12.0 million in 2023, then dropped by 0.74% to $11.9 million in 2024, then grew by 9.59% to $13.1 million in 2025.
  • Its last three reported values are $13.1 million in Q3 2025, $12.7 million for Q2 2025, and $12.3 million during Q1 2025.